Corevalve Evolut R
Payments companies reported to CMS as associated with Corevalve Evolut R. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Corevalve Evolut R, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Corevalve Evolut R
These are the largest totals companies reported as associated with Corevalve Evolut R. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Caskey | Phoenix, AZ | $1,952,462.60 | |
| Hemal Gada | Wormleysburg, PA | Cardiovascular Disease | $578,334.25 |
| Guilherme Attizzani | Cleveland, OH | Cardiovascular Disease | $561,384.32 |
| Nishant Sethi | Scranton, PA | Interventional Cardiology | $376,443.15 |
| Basel Ramlawi | Wynnewood, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $322,787.28 |
| Saurabh Gupta | Bend, OR | Interventional Cardiology | $278,335.02 |
| Clinton Kemp | Norfolk, VA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $258,336.12 |
| Michael Reardon | Houston, TX | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $251,599.87 |
| Gilbert Tang | New York, NY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $226,811.56 |
| Gregory Fontana | Thousand Oaks, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $214,192.64 |
Prescribed Corevalve Evolut R?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.